Results 181 to 190 of about 9,537,389 (233)

Necrotising granulomatous epididymo-orchitis in the setting of Crohn's disease. [PDF]

BMJ Case Rep
Talbot T, Talbot A, Picardo S, Chakravorty A.   +3 more
europepmc   +1 more source

The emerging role of CRISPR-Cas systems in helicobacter pylori and the gut microbiota as regulators of gastrointestinal cancer risk. [PDF]

Front Immunol
Bhatti M, Thalib HI, Tayyebah A, Zobairi A, Dahan N, Hassan FE.   +5 more
europepmc   +1 more source

Fecal metagenomic profiling in patients with colorectal adenomas to characterize gut microbial composition and functional potential. [PDF]

Front Microbiol
Zhili G, Jie L, Yuyue X, Fang Y, Dianqun R, Qin Z, Xiaojun L.   +6 more
europepmc   +1 more source

Gut microbiota-mediated chemotherapy resistance in colorectal cancer: mechanisms and precision interventions. [PDF]

Front Oncol
Li Y, Wang F, Li T, Liu Y.
europepmc   +1 more source

Distinct prophage infections in colorectal cancer-associated Bacteroides fragilis. [PDF]

Commun Med (Lond)
Damgaard F, Jespersen MG, Møller JK, Coia JE, Dessau RB, Sydenham TV, Strube ML, Møller-Jensen J, Justesen US.   +8 more
europepmc   +1 more source

Storage-associated shifts in the raw boar seminal microbiome at 17 °C. [PDF]

Front Vet Sci
Carrasco-Zambrano N, Leal K, Machuca J, Núñez-Montero K, Pezo F, Contreras MJ.   +5 more
europepmc   +1 more source

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe [PDF]

Clinical Microbiology and Infection, 2003
ObjectiveTo evaluate the activity of old and newer antianaerobic drugs against clinical isolates of Bacteroides fragilis group strains from different parts of Europe.MethodsBacteroides fragilis group isolates from 37 laboratories in 19 countries were ...
Maria Hedberg, C E Nord
exaly   +4 more sources